(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | --281.55M | 35.61%713M | 24.17%468.44M | 15.87%525.77M | --377.25M | 55.87%453.76M | --291.12M |
Operating income | 281.55M | 35.61%713M | 24.17%468.44M | 15.87%525.77M | 377.25M | 55.87%453.76M | 291.12M |
Cost of sales | ---171.24M | -38.36%-430.97M | -50.26%-332.12M | -31.09%-311.48M | ---221.03M | -51.52%-237.6M | ---156.81M |
Operating expenses | -171.24M | -38.36%-430.97M | -50.26%-332.12M | -31.09%-311.48M | -221.03M | -51.52%-237.6M | -156.81M |
Gross profit | 110.31M | 31.61%282.03M | -12.74%136.32M | -0.87%214.29M | 156.23M | 60.95%216.16M | 134.31M |
Selling expenses | ---80.16M | -105.13%-202.82M | -115.41%-149.14M | 25.50%-98.88M | ---69.23M | -70.38%-132.73M | ---77.9M |
Administrative expenses | ---38.05M | -130.04%-169.09M | -160.71%-144.94M | 46.38%-73.5M | ---55.59M | -144.76%-137.09M | ---56.01M |
Research and development expenses | ---102.6M | -30.27%-187.96M | -24.83%-135.46M | -4.72%-144.28M | ---108.51M | -20.71%-137.78M | ---114.14M |
Impairment and provision | ---3.81M | -378.47%-5.82M | 19.21%-1.28M | 30.50%-1.22M | ---1.59M | -121.09%-1.75M | ---792K |
-Other impairment is provision | ---3.81M | -378.47%-5.82M | 19.21%-1.28M | 30.50%-1.22M | ---1.59M | -121.09%-1.75M | ---792K |
Special items of operating profit | ---24.33M | -144.77%-21.45M | -135.00%-16.85M | -76.40%-8.76M | ---7.17M | -440.67%-4.97M | --1.46M |
Operating profit | -138.64M | -171.57%-305.11M | -262.56%-311.35M | 43.30%-112.35M | -85.88M | -75.24%-198.15M | -113.08M |
Financing income | --1.5M | -33.30%6.88M | -31.62%5.47M | -2.54%10.31M | --8.01M | 168.60%10.58M | --3.94M |
Financing cost | ---252K | 34.78%-1.02M | 33.83%-806K | -544.86%-1.57M | ---1.22M | 67.07%-243K | ---738K |
Share of profits of associates | ---5.22M | -476.99%-4.03M | -92.76%-4.52M | -78.44%1.07M | ---2.35M | -29.00%4.96M | --6.98M |
Special items of earning before tax | ---302.99M | -4.49%-55.9M | 581.55%97.8M | 79.85%-53.49M | ---20.31M | 7.13%-265.52M | ---285.91M |
Earning before tax | -445.6M | -130.20%-359.17M | -109.75%-213.41M | 65.20%-156.03M | -101.74M | -15.32%-448.37M | -388.8M |
Tax | ---200K | 41.71%-116K | 60.33%-48K | ---199K | ---121K | ---- | ---- |
After-tax profit from continuing operations | -445.8M | -129.98%-359.29M | -109.55%-213.46M | 65.16%-156.22M | -101.87M | -15.32%-448.37M | -388.8M |
Earning after tax | -445.8M | -129.98%-359.29M | -109.55%-213.46M | 65.16%-156.22M | -101.87M | -15.32%-448.37M | -388.8M |
Minority profit | ---297K | 51.89%-1.31M | 45.43%-1.19M | -89.76%-2.72M | ---2.18M | ---1.44M | ---- |
Profit attributable to shareholders | -445.51M | -133.21%-357.98M | -112.93%-212.27M | 65.65%-153.5M | -99.69M | -14.95%-446.94M | -388.8M |
Basic earnings per share | -3.18 | -132.73%-2.56 | -114.08%-1.52 | 65.52%-1.1 | -0.71 | -14.75%-3.19 | -2.78 |
Diluted earnings per share | -3.18 | -132.73%-2.56 | -114.08%-1.52 | 65.52%-1.1 | -0.71 | -14.75%-3.19 | -2.78 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data